High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning

Clinical Toxicology

Volumn 49, Issue 4, 2011, Pages 277-283

  Engebretsen, Kristin M ^a   Kaczmarek, Kathleen M ^b   Morgan, Jenifer ^b   Holger, Joel S ^a  

^a REGIONS HOSPITAL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Beta blocker; Calcium channel blocker; High dose insulin; Poisoning

Indexed keywords

ADRENALIN; AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHLORIDE; DILTIAZEM; GLUCAGON; GLUCOSE; INSULIN; METOPROLOL; NEBIVOLOL; POTASSIUM; PROPRANOLOL; VASOPRESSIN; VERAPAMIL;

CARDIOGENIC SHOCK; CELL TRANSPORT; CLINICAL PROTOCOL; CONTINUOUS INFUSION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDICATION; DRUG INTOXICATION; DRUG MEGADOSE; DRUG OVERDOSE; DRUG WITHDRAWAL; EXTRACELLULAR SPACE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HEART ARRHYTHMIA; HUMAN; HYPOGLYCEMIA; HYPOKALEMIA; INOTROPISM; INSULIN TREATMENT; INTRACELLULAR SPACE; NONHUMAN; POTASSIUM BLOOD LEVEL; RECOMMENDED DRUG DOSE; REVIEW; SURVIVAL RATE; VASODILATATION;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CALCIUM CHANNEL BLOCKERS; HUMANS; INSULIN;

ANIMALIA;

EID: 79956073552     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2011.582471     Document Type: Review

References (63)

1. Shepherd G, Klein-Schwartz W. High-dose insulin therapy for calcium-channel blocker overdose. Ann Pharmacother 2005; 39:923-930. (Pubitemid 40570672)
2. Verbrugge LB, Van Wezel HB. Pathophysiology of verapamil overdose: new insights in the role of insulin. J Cardiothor Vasc Anesth 2007; 21:406-409. (Pubitemid 46830971)
3. Salhanick SD, Shannon MW. Management of calcium channel antagonist overdose. Drug Saf 2003; 26:65-79. (Pubitemid 36188558)
4. Newton CR, Delgado JH, Gomez HF. Calcium and beta receptor antagonist overdose: a review and update of pharmacological principles and management. Sem Respir Crit Care Med 2002; 23: 19-25. (Pubitemid 34208055)
5. Lheureux P, Zahir S, Gris M, Derrey AS, Penaloza A. Bench-tobedside review: Hyperinsulinaemia/euglycaemia therapy in the management of overdose of calcium-channel blockers. Crit Care 2006; 10:212-217.
6. Cumpston K, Mycyk M, Pallash E, Manzanares M, Knight J, Aks S, Hryhorczuk D. Failure of hyperinsulinemia/euglycaemia therapy in severe diltiazem overdose [Abstract]. J Toxicol Clin Toxicol 2002; 40:618.
7. Stellpflug SJ, Fritzlar SJ, Cole JB, Engebretsen KM, Holger JS. Cardiotoxic overdose treated with intravenous fat emulsion and highdose insulin in the setting of hypertrophic cardiomyopathy. J Med Toxicol DOI:10.1007/s13181-010-0133-3.
8. Holger JS, Engebretsen KM, Marini JJ. High dose insulin in toxic cardiogenic shock. Clin Toxicol 2009; 47:303-307.
9. Shepherd G. Treatment of poisoning caused by beta-adrenergic and calcium-channel blockers. Amer J Health-Syst Pharm 2006; 63: 1828-1835. (Pubitemid 44477454)
10. Boyer EW, Shannon M. Treatment of calcium-channel-blocker intoxication with insulin infusion. N Engl J Med 2001; 344: 1721-1722. (Pubitemid 32479976)
11. Hasin T, Leibowitz D, Antopolsky M, Chajek-Shaul T. The use of low dose insulin in cardiogenic shock due to combined overdose of verapamil, enalapril and metoprolol. Cardiology 2006; 106:233-236. (Pubitemid 44763176)
12. Bailey B. Glucagon in beta-blocker and calcium channel blocker overdoses: a systematic review. J Toxicol Clin Toxicol 2003; 41: 595-602. (Pubitemid 37102385)
13. Freestone S, Thomas HM, Bhamra RK, Dyson EH. Severe atenolol poisoning: treatment with prenalterol. Hum Toxicol 1986; 5:343-345. (Pubitemid 16049617)
14. Hurwitz MD, Kallenbach JM, Pincus PS. Massive propranolol overdose. Am J Med 1986; 81:1118.
15. Shore ET, Cepin D, Davidson MJ. Metoprolol overdose. Ann Emerg Med 1981; 10:524-527. (Pubitemid 12087020)
16. Love JN, Hanfling D, Howell JM. Hemodynamic effects of calcium chloride in a canine model of acute propranolol intoxication. Ann Emerg Med 1996; 28:1-6. (Pubitemid 26227377)
17. Pertoldi F, D'Orlando L, Mercante WP. Electromechanical dissociation 48 hours after atenolol overdose: usefulness of calcium chloride. Ann Emerg Med 1998; 31:777-781. (Pubitemid 28252638)
18. Isbister GK. Delayed asystolic cardiac arrest after diltiazem overdose; resuscitation with high dose intravenous calcium. Emerg Med J 2002; 19:355-357. (Pubitemid 34830497)
19. Crump BJ, Holt DW, Vale JA. Lack of response to intravenous calcium in severe verapamil poisoning. Lancet 1982; 2:939-940. (Pubitemid 12028432)
20. Lam YM, Tse HF, Lau CP. Continuous calcium chloride infusion for massive nifedipine overdose. Chest 2001; 119:1280-1282.
21. Holger JS, Dries DJ, Barringer KW. Cardiovascular and metabolic effects of high-dose insulin in a porcine septic shock model. Acad Emerg Med 2010; 17:429-435.
22. VonLewinski D, Bruns S, Walther S, Kögler H, Pieske B. Insulin causes [Ca2+] i-dependent and [Ca2+]i-independent positive inotropic effects in failing human myocardium. Circulation 2005; 111:2588-2595. (Pubitemid 40740857)
23. Bechtel LK, Haverstick DM, Holstege CP. Verapamil toxicity dysregulates the phosphatidylinositol 3-kinase pathway. Acad Emerg Med 2008; 15:368-374.
24. Hsu CH, Wei J, Chen YC, Yang SP, Tsai CS, Lin CI. Cellular mechanisms responsible for the inotropic action of insulin on failing human myocardium. J Heart Lung Transplant 2006; 25:1126-1134. (Pubitemid 44311528)
25. Kline JA, Raymond RM, Schroeder JD, Watts JA. The diabetogenic effects of acute verapamil poisoning. Toxicol Appl Pharmacol 1997; 145:357-362. (Pubitemid 27346525)
26. Kline JA, Tomaszewski CA, Schroeder JD, Raymond RM. Insulin is a superior antidote for cardiovascular toxicity induced by verapamil in the anesthetized canine. J Pharmacol Exp Ther 1993; 267:744-750. (Pubitemid 23352533)
27. Kline JA, Lenova E, Raymond RM. Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine. Crit Care Med 1995; 23:1251-1263.
28. Kline JA, Lenova E, Williams TC, Schroeder JD, Watts JA. Myocardial metabolism during graded intraportal verapamil infusion in awake dogs. J Cardiovasc Pharmacol 1996; 27:719-726. (Pubitemid 26134249)
29. Kline JA, Raymond RM, Leonova ED, Williams TC, Watts JA. Insulin improves heart function and metabolism during non-ischemic cardiogenic shock in awake canines. Cardiovasc Res 1997; 34:289-298. (Pubitemid 27241573)
30. Krukenkamp I, Sørlie D, Silverman N, Pridjian A, Levitsky S. Direct effect of high-dose insulin on the depressed heart after beta-blockade of ischemia. Thorac Cardiovasc Surg 1986; 34:305-309. (Pubitemid 16010729)
31. Kerns W 2nd, Shroeder D, Williams C, Tomaszewski C, Raymond R. Insulin improves survival in a canine model of acute b-blocker toxicity. Ann Emerg Med 1997; 29:748.
32. Holger JS, Engebretsen KM, Fritzlar SJ, Patten LC, Harris CR, Flottemesch TJ. Insulin versus vasopressin and epinephrine to treat beta-blocker toxicity. Clin Toxicol 2007; 45:396-401. (Pubitemid 46718126)
33. Engebretsen KM, Morgan MW, Stellpflug SJ, Cole JB, Anderson CP, Holger JS. Addition of phenylephrine to high-dose insulin in dihydropyridine overdose does not improve outcome. Clin Toxicol 2010; 48:806-812.
34. Holger JS, Engebretsen KM, Stellpflug SJ, Cole JB, Cooper AC, Harris CR. A consecutive case series [abstract]. Clin Toxicol 2010; 48:613.
35. Page CB, Hacket LP, Isbister GK. The use of high-dose insulinglucose euglycemia in beta-blocker overdose: A case report. J Med Toxicol 2009; 5:139-142.
36. Aaronson PM, Wassil SK, Kunisaki TA. Hyperinsulinemia euglycemia, continuous veno-venous hemofiltration, and extracorporeal list support for severe verapamil poisoning: Case report [abstract]. Clin Toxicol 2009; 47:742.
37. Yuan TH, Kerns WP 2nd, Tomaszewski CA, Ford MD, Kline JA. Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning. Clin Toxicol 1999; 37:463-474. (Pubitemid 29387890)
38. Rasmussen L, Husted SE, Johnsen SP. Severe intoxication after an intentional overdose of amlodipine. Acta Anaesthesiol Scand 2003; 47:1038-1040. (Pubitemid 37013782)
39. Marques M, Gomez E, de Oliveira J. Treatment of calcium channel blocker intoxication with insulin infusion: case report and literature review. Resuscitation 2003; 57:211-213. (Pubitemid 36556190)
40. Herbert JX, O'Malley C, Tracey JA, Dwyer R, Power M. Verapamil overdosage unresponsive to insulin/dextrose therapy [abstract]. J Toxicol Clin Toxicol 2001; 39:293-294.
41. Place R, Carlson A, Leikin J, Hanashiro P. Hyperinsulin therapy in the treatment of verapamil overdose [abstract]. J Toxicol Clin Toxicol 2000; 38:576-577.
42. Engebretsen KM, Holger JS, Harris CR. Therapeutic misadventure of high dose insulin without adverse effects [abstract]. Clin Toxicol 2008; 26:604.
43. Cumpston KL, Rose SR. Titration of hyperinsulinemia euglycemia therapy for the treatment of acute diltiazem toxicity [Abstract]. Clin Toxicol 2009; 47:724.
44. Harris NS. Case 24-2006: A 40-year-old woman with hypotension after an overdose of amlodipine. N Engl J Med 2006; 355:602-611. (Pubitemid 44200654)
45. Vogt S, Mehlig A, Hunziker P, Scholer A, Jung J, González AB. Survival of severe amlodipine intoxication due to medical intensive care. Forensic Sci Int 2006; 161:216-220. (Pubitemid 44142911)
46. Smith SW, Ferguson KL, Hoffman RS, Nelson LS, Greller HA. Prolonged severe hypotension following combined amlodipine and valsartan ingestion. Clin Toxicol 2008; 46:470-474. (Pubitemid 351878649)
47. Min L, Deshpande K. Diltiazem overdose haemodynamic response to hyperinsulinaemia-euglycaemia therapy: a case report. Crit Care Resusc 2004; 6:28-30.
48. Stellpflug SJ, Harris CR, Engebretsen KM, Cole JB, Holger JS. Intentional overdose with cardiac arrest treated with intravenous fat emulsion and high-dose insulin. Clin Toxicol 2010; 48:227-229.
49. Pizon AF, LoVecchio F, Matesick LF. Calcium channel blocker overdose: one center's experience [abstract]. Clin Toxicol 2005; 43:679-680.
50. Bryant SM, Espinoza TR, Aks SE. Seven years of high dose insulin therapy for calcium channel antagonist poisoning [abstract]. Clin Toxicol 2009; 27:751.
51. Dolcourt BA, Hedge MW. Hyperinsulinemic euglycemic therapy for symptomatic amiodarone ingestion [abstract]. Clin Toxicol 2009; 47:717.
52. Boyer EW, Shannon M. Treatment of calcium-channel-blocker intoxication with insulin infusion. N Engl J Med 2001; 344:1721-1722. (Pubitemid 32479976)
53. Goldberg J, Wadhwa A, Shrestha M. Glucagon treatment of combined beta-blocker and calcium channel blocker toxicity [abstract]. Clin Toxicol 2002; 40:351.
54. Morris-Kukoski CL, Biswas AK, Parra M, Smith C. Insulin "euglycemia" therapy for accidental nifedipine overdose [abstract]. Clin Toxicol 2000; 38:577.
55. Yuan T, Tomaszewski C, Ford M, Kline J. Insulin and glucose: novel treatment for calcium antagonist-induced shock [abstract]. Clin Toxicol 1997; 35:563.
56. Engebretsen KM, Holger JS, Marini JJ. High dose insulin in multiple drug overdose [abstract]. Clin Toxicol 2007; 45:622.
57. Simmons R, Johnson D, Clancy C, Litovitz T. Patient disposition after sustained-release calcium channel blocker (SR CCB) ingestion [abstract]. Clin Toxicol 1999; 37:627.
58. Bilbault P, Castelain V, Meziani F, Harlay ML, Mathien C, Pynn S, et al. Is digoxin poisoning improved by insulin? A case report [abstract]. Clin Toxicol 2005; 43:511.
59. Greene SL, Gawarammana I, Wood DM, Jones AL, Dargan PI. Relative safety of hyperinsulinaemia/euglycaemia therapy in the management of calcium channel blocker overdose: a prospective observational study. Intensive Care Med 2007; 33:2019-2024. (Pubitemid 47632262)
60. Reikerås, O, Gunnes P, Sørlie D, Ekroth R, Jorde R, Mjøs OD. Haemodynamic effect of low and high doses of insulin during beta receptor blockade in dogs. Clin Physiol 1985; 5:455-467.
61. Boerma EC, Ince C. The role of vasoactive agents in the resuscitation of microvascular perfusion and tissue oxygenation in critically ill patients. Intensive Care Med 2010; 36:2004-2018.
62. Patel NP, Pugh ME, Goldberg S, Eiger G. Hyperinsulinemic euglycemia therapy for verapamil poisoning: A review. Am J Crit Care 2007; 16:498-503.
63. Bechtel LK, Haverstick DM, Holstege CP. Verapamil toxicity dysregulates the phosphatidylinositol 3-kinase pathway. Acad Emerg Med 2008; 15:368-374.